Rephonic
Artwork for BiotechTV

BiotechTV - News

BiotechTV
FDA
Biotech
Clinical Trials
Car-T Therapy
Obesity
Biotechnology
Oncology
Artificial Intelligence
Breast Cancer
Gene Therapy
Parkinson's Disease
Multiple Myeloma
Immunology
Mergers and Acquisitions
Takeda
Ulcerative Colitis
TYK2
Gene Editing
Biotech Industry
Rare Disease

This is the primary news channel of BiotechTV where you will find on the ground reporting by our journalists from biotech hubs throughout the world.

PublishesDailyEpisodes448Founded2 years ago
Number of ListenersCategories
Life SciencesScience

Listen to this Podcast

Artwork for BiotechTV

Latest Episodes

Co-Founder, President & CEO Greg Verdine describes the toxicity issues associated with the immuosupressive drugs that transplant recipients currently receive, and explains how LIFE-001 is different. Plus, given how the therapy is designed to safely p... more

Dr. Berger, who founded Ariad Pharmaceuticals here in 1991, describes Kendall's transition from candy factories, to Polaroid, to what it is today.

Jim Olaghere describes signing up for a gene editing treatment clinical trial for sickle cell disease and how it has enabled him to climb mountains and Bob Coughlin recounts the moment when a therapy became available for his son's cystic fibrosis.

Alexis Borisy recounts the story of Revolution Medicines, which delivered the pancreatic cancer breakthrough this year, and talks about the health of the founder led side of the biotech sector. Mathai Mammen recently took Parabilis public in the larg... more

Key Facts

Accepts Guests
Accepts Sponsors
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Biotech Hangout
Biotech HangoutDaphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler and more

Recent Guests

Greg Verdine
Co-founder, president, and CEO of LifeMine Therapeutics; renowned scientist
LifeMine Therapeutics
Episode: LifeMine Therapeutics announced a $263M raise today to help accelerate the development of its novel calcineurin activation inhibitor that aims to radically change the profile of organ transplants
Harvey Berger
Founder of Ariad Pharmaceuticals; Kendall Square OG
Ariad Pharmaceuticals, Dana-Farber Board of Trustees
Episode: U.S. Science Summit: Biotech veteran Harvey Berger presents an overview of the history of Kendall Square and what is at stake to keep it a leader in life sciences
Jimi Olaghere
One of the first people to receive CRISPR gene therapy for sickle cell disease; principal at Sugarloaf Capital
Sugarloaf Capital
Episode: U.S. Science Summit: Patient perspectives with sickle cell patient advocate Jimi Olaghere and cystic fibrosis advocate Bob Coughlin
Bob Coughlin
Former president and CEO of MassBio; chair of their life sciences practice at JLL
MassBio / JLL
Episode: U.S. Science Summit: Patient perspectives with sickle cell patient advocate Jimi Olaghere and cystic fibrosis advocate Bob Coughlin
Alexis Borisy
Co-founder of Curie Bio and biotech investor
Curie Bio
Episode: U.S. Science Summit: Curie.Bio Chairman Alexis Borisy and Parabilis Medicines CEO Mathai Mammen discusses the funding environment for biotech and communicating their work to the public
Noubar Afeyan
Founder and CEO of Flagship Pioneering
Flagship Pioneering
Episode: U.S. Science Summit: Flagship Pioneering Founder & CEO Noubar Afeyan discusses his early days in Cambridge and the opportunities it afforded him, science communication, immigrants, and more
Najat Khan
CEO and President of Recursion
Recursion Pharmaceuticals
Episode: U.S. Science Summit: "Who will shape the future of Bio?" with Recursion President & CEO Najat Khan
Dr. Gabb Astorga
Science communicator and researcher
Episode: U.S. Science Summit: Three science communicator social media all-stars share their stories and offer advice on how to tell science stories that resonate with a broad audience
Maynard Okereke
Content creator, science communicator
Hip Hop Science
Episode: U.S. Science Summit: Three science communicator social media all-stars share their stories and offer advice on how to tell science stories that resonate with a broad audience

Host

Brad
Brad, on-air host with multiple segments including BiotechTV - News and biotech innovation coverage.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

LifeMine Therapeutics announced a $263M raise today to help accelerate the development of its novel calcineurin activation inhibitor that aims to radically change the profile of organ transplants
Q: How does LifeMine's calcineurin inhibitor differ from tacrolimus in mechanism and toxicity profile?
Our inhibitor is not a molecular glue like tacrolimus; it focuses on a different engagement with calcineurin, achieving blood-centric distribution that avoids brain exposure and reduces off-target organ toxicities, leading to a favorable safety margin observed in GLP tox studies and healthy volunteer data.
LifeMine Therapeutics announced a $263M raise today to help accelerate the development of its novel calcineurin activation inhibitor that aims to radically change the profile of organ transplants
Q: Tell us what LifeMine has raised and what this financing allows you to do next.
LifeMine has raised $263 million across two rounds, providing enough capital to advance our calcineurin inhibitor program through phase two trials, including a large renal transplant study with a tacrolimus comparator, and to explore autoimmunity indications with a second molecule in the series.
U.S. Science Summit: Dr. Elias Zerhouni discusses the source of what made the United States strong in medical research decades ago and what is at stake to keep supporting it today
Q: How can scientists and institutions better describe and defend the value of biomedical research to the general public before policy changes are proposed?
By engaging early with patient groups, clearly communicating benefits and timelines of research, and leveraging modern channels like social media and targeted messaging to reach specific audiences, thus building broad public understanding and resilience against short-sighted cuts.
U.S. Science Summit: Dr. Elias Zerhouni discusses the source of what made the United States strong in medical research decades ago and what is at stake to keep supporting it today
Q: As former NIH director, what would a 40% NIH budget cut mean for science and the United States?
The answer emphasizes that while such cuts may be technically possible, the real impact would be devastating: slower progress, lost jobs, fewer therapies reaching patients, and a damaged global competitiveness that could erode public trust in science.
U.S. Science Summit: "Who will shape the future of Bio?" with Recursion President & CEO Najat Khan
Q: How can AI realistically change patient outcomes over the next decade, and what skills are needed for the next generation?
AI, data, and compute must be integrated into a transparent, rigorous product engine that accelerates the path from discovery to clinic, while nurturing systems thinkers who can connect biology and technology and who value collaboration, humility, and continuous learning.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About BiotechTV

What is BiotechTV about and what kind of topics does it cover?

BiotechTV's news-focused episodes center on on-the-ground reporting from biotech hubs, with detailed conversations around company strategy, clinical data, regulatory developments, and industry dynamics. Frequent guests are biotech executives, founders, investors, scientists, and policy or communications leaders who offer firsthand insight into programs, financing, FDA decisions, and innovation pipelines. Notable strengths include high-signal interviews with senior leaders discussing IPOs, novel platforms, and strategic pivots, plus timely coverage of conferences and breaking industry news. The show likely appeals to biotech executives, investors, researchers, and professionals who want practical context for emerging therapies, diagnostic to... more

Where can I find podcast stats for BiotechTV?

Rephonic provides a wide range of podcast stats for BiotechTV. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to BiotechTV and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does BiotechTV get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for BiotechTV, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for BiotechTV?

Rephonic provides comprehensive predictive audience data for BiotechTV, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does BiotechTV have?

To see how many followers or subscribers BiotechTV has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to BiotechTV?

These podcasts share a similar audience with BiotechTV:

1. Biotech Hangout
2. BioCentury This Week
3. The Readout Loud
4. BioVenture VoiCes with Chris Garabedian
5. The BioCentury Show

How many episodes of BiotechTV are there?

BiotechTV launched 2 years ago and published 448 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact BiotechTV?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for BiotechTV?

Rephonic pulls ratings and reviews for BiotechTV from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for BiotechTV?

Rephonic provides full transcripts for episodes of BiotechTV. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on BiotechTV?

Recent guests on BiotechTV include:

1. Greg Verdine
2. Harvey Berger
3. Jimi Olaghere
4. Bob Coughlin
5. Alexis Borisy
6. Noubar Afeyan
7. Najat Khan
8. Dr. Gabb Astorga

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days